Skip to main content
SpringerLink
Log in

Dual chronic hepatitis B virus and hepatitis C virus infection

  • REVIEW ARTICLE
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Dual hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are common in HBV or HCV endemic areas. However, several clinical and pathogenetic issues remain unresolved. First, clinical and in vitro studies suggest the interactions between two viruses. The dynamics of the interaction in untreated setting versus treated setting and its influence on the long-term outcomes await further studies. A key issue regarding viral interactions is whether modulation of infection occurs in the same dually infected individual hepatocyte of the liver. Clarifying this issue may help to understand the reciprocal interference between HCV and HBV and provide clues for future immunopathogenetic studies. Second, the prevalence and clinical significance of coexisting occult HBV infection in patients with chronic HCV infection need further investigations. Third, combination therapy of peginterferon alfa-2a and ribavirin appears to be just as effective and safe for the treatment of hepatitis B surface antigen (HBsAg)-positive patients chronically infected with active chronic hepatitis C as it is in patients with HCV monoinfection. Nevertheless, one-third of dually infected patients with nondetectable serum HBV DNA-level pretreatment developed HBV reactivation posttreatment. How to prevent and treat this reactivation should be clarified. Furthermore, about 10% of the dually infected patients lost HBsAg. Underlying mechanisms await further investigations. Finally, the optimal treatment strategies for dually infected patients with hepatitis B e antigen-positive chronic hepatitis B should be identified in future clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Liu CJ, Liou JM, Chen DS, Chen PJ. Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections. J Formos Med Assoc 2005;104:783–791

    PubMed  Google Scholar 

  2. Chen DS, Kuo G, Sung JL, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990;162:817–822

    CAS  PubMed  Google Scholar 

  3. Liu CJ, Chen PJ, Shau WY, et al. Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study. Liver Int 2003;23:148–155

    Article  PubMed  Google Scholar 

  4. Custer B, Sullivan SD, Hazlet TK, et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004;38(10 Suppl 3):S158–S168

    Article  PubMed  Google Scholar 

  5. Li W, Zhu Y, Hua Z. Exploration on the association between the pattern of HBV markers and infection of HCV among population. Zhonghua Liu Xing Bing Xue Za Zhi 1994;15:212–214

    CAS  PubMed  Google Scholar 

  6. Chen X, Xuan M, Wu D. Study of super-infection of HBV and HCV. Zhonghua Liu Xing Bing Xue Za Zhi 1999;20:141–143

    CAS  PubMed  Google Scholar 

  7. Gaeta GB, Stornaiuolo G, Precone DF, et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol 2003;39:1036–1041

    Article  PubMed  Google Scholar 

  8. D’Amelio R, Matricardi PM, Biselli R, et al. Changing epidemiology of hepatitis B in Italy: public health implications. Am J Epidemiol 1992;135:1012–1018

    PubMed  Google Scholar 

  9. Pramoolsinsap C, Sirikulchayanonta V, Busakorn W, et al. Coinfections with hepatitis G and/or C virus in hepatitis B-related chronic liver disease. Southeast Asian J Trop Med Public Health 1999;30:741–749

    CAS  PubMed  Google Scholar 

  10. Shiratori Y, Shiina S, Zhang PY, et al. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer 1997;80:2060–2067

    Article  CAS  PubMed  Google Scholar 

  11. Crespo J, Lozano JL, de la Cruz F, et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 1994;89:1147–1151

    CAS  PubMed  Google Scholar 

  12. Treitinger A, Spada C, Ferreira LA, et al. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianopolis—Brazil. Braz J Infect Dis 2000;4:192–196

    CAS  PubMed  Google Scholar 

  13. Xess A, Kumar M, Minz S, et al. Prevalence of hepatitis B and hepatitis C virus coinfection in chronic liver disease. Indian J Pathol Microbiol 2001;44:253–255

    CAS  PubMed  Google Scholar 

  14. Kaur S, Rybicki L, Bacon BR, et al. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group. Hepatology 1996;24:979–986

    CAS  PubMed  Google Scholar 

  15. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887–891

    Article  CAS  PubMed  Google Scholar 

  16. el-Sayed HF, Abaza SM, Mehanna S, et al. The prevalence of hepatitis B and C infections among immigrants to a newly reclaimed area endemic for Schistosoma mansoni in Sinai, Egypt. Acta Trop 1997;68:229–237

    Article  CAS  PubMed  Google Scholar 

  17. Sagnelli E, Coppola N, Messina V, et al. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course. Hepatology 2002;36:1285–12891

    Article  PubMed  Google Scholar 

  18. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004;126:1024–1029

    Article  PubMed  Google Scholar 

  19. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998;75:347–354

    Article  CAS  PubMed  Google Scholar 

  20. Potthoff A, Deterding K, Trautwein C, Rifai K, Manns MP, Wedemeyer H. Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-co-infected patient. Eur J Gastroenterol Hepatol 2007;19:906–909

    Article  CAS  PubMed  Google Scholar 

  21. Liu CJ, Chuang WL, Lee CM, et al. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 2009;136:496–504

    Article  CAS  PubMed  Google Scholar 

  22. Gordon SC, Sherman KE. Treatment of HBV/HCV coinfection: releasing the enemy within. Gastroenterology 2009;136:393–396

    Article  PubMed  Google Scholar 

  23. Brotman B, Prince AM, Huima T, Richardson L, van den Ende MC, Pfeifer U. Interference between non-A, non-B and hepatitis B virus infection in chimpanzees. J Med Virol 1983;11:191–205

    Article  CAS  PubMed  Google Scholar 

  24. Fattovich G, Tagger A, Brollo L, et al. Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis 1991;163:400–402

    CAS  PubMed  Google Scholar 

  25. Sato S, Fujiyama S, Tanaka M, et al. Co-infection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994;21:159–166

    Article  CAS  PubMed  Google Scholar 

  26. Sheen IS, Liaw YF, Chu CM, Pao CC. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. J Infect Dis 1992;165:831–834

    CAS  PubMed  Google Scholar 

  27. Chu CM, Yeh CT, Liaw YF. Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection. J Clin Microbiol 1998;36:2084–2086

    CAS  PubMed  Google Scholar 

  28. Jardi R, Rodriguez F, Buti M, et al. Rule of hepatitis B, C and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001;34:404–410

    Article  CAS  PubMed  Google Scholar 

  29. Liaw YF. Hepatitis C virus super-infection in patients with chronic hepatitis B virus infection. J Gastroenterol 2002;37(Suppl 13):65–68

    Article  PubMed  Google Scholar 

  30. Liaw YF, Lin SM, Sheen IS, Chu CM. Acute hepatitis C virus super-infection followed by spontaneous HBeAg seroconversion and HBsAg elimination. Infection 1991;19:250–251

    Article  CAS  PubMed  Google Scholar 

  31. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993;67:5823–5832

    CAS  PubMed  Google Scholar 

  32. Shih CM, Chen CM, Chen SY, Lee YH. Modulation of the transsuppression activity of hepatitis C virus core protein by phosphorylation. J Virol 1995;69:1160–1171

    CAS  PubMed  Google Scholar 

  33. Schuttler CG, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 2002;37:855–862

    Article  CAS  PubMed  Google Scholar 

  34. Chen SY, Kao CF, Chen CM, et al. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 2003;278:591–607

    Article  CAS  PubMed  Google Scholar 

  35. Pasquinelli C, Shoenberger JM, Chung J, et al. Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology 1997;25:719–727

    Article  CAS  PubMed  Google Scholar 

  36. Pan Y, Wei W, Kang L, et al. NS5A protein of HCV enhances HBV replication and resistance to interferon response. Biochem Biophys Res Commun 2007;359:70–75

    Article  CAS  PubMed  Google Scholar 

  37. Guo H, Zhou T, Jiang D, et al. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase akt signal transduction pathway. J Virol 2007;81:10072–10080

    Article  CAS  PubMed  Google Scholar 

  38. Zarski JP, Bohn B, Bastie A, et al. Characteristic of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998;28:27–33

    Article  CAS  PubMed  Google Scholar 

  39. Ohkawa K, Hayashi N, Yuki N, et al. Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol 1994;21:509–514

    Article  CAS  PubMed  Google Scholar 

  40. Ohkawa K, Hayashi N, Yuki N, et al. Long-term follow up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients co-infected with both viruses. J Med Virol 1995;46:258–264

    Article  CAS  PubMed  Google Scholar 

  41. Pontisso P, Gerotto M, Ruvoletto MG, et al. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection. J Med Virol 1996;48:157–160

    Article  CAS  PubMed  Google Scholar 

  42. Bellecave P, Gouttenoire J, Gajer M, et al. Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference. Hepatology 2009;50:46–55

    Article  CAS  PubMed  Google Scholar 

  43. Raimondo G, Brunetto MR, Pontisso P, et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-co-infected patients. Hepatology 2006;43:100–107

    Article  PubMed  Google Scholar 

  44. Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 2005;79:9369–9380

    Article  CAS  PubMed  Google Scholar 

  45. Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008;49:652–657

    Article  PubMed  Google Scholar 

  46. Li L, Chen PJ, Chen MH, et al. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion 2008;48:1198–1206

    Article  CAS  PubMed  Google Scholar 

  47. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999;341:22–26

    Article  CAS  PubMed  Google Scholar 

  48. Fukuda R, Ishimura N, Hamamoto S, et al. Co-infection by serologically silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver. J Med Virol 2001;63:220–227

    Article  CAS  PubMed  Google Scholar 

  49. Sagnelli E, Copolla N, Colastico C, et al. HCV genotype and “silent” HBV infection: two main risk factors for a more severe liver disease. J Med Virol 2001;64:350–355

    Article  CAS  PubMed  Google Scholar 

  50. Paterlini P, Driss F, Nalpas B, et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 1993;17:20–29

    Article  CAS  PubMed  Google Scholar 

  51. Koike K, Kobayashi M, Gondo M, Hayashi I, Osuga T, Takada S. Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients. J Med Virol 1998;54:249–255

    Article  CAS  PubMed  Google Scholar 

  52. De Maria N, Colantoni A, Friedlander L, et al. The impact of previous HBV infection on the course of chronic hepatitis C. Am J Gastroenterol 2000;95:3529–3536

    Article  PubMed  Google Scholar 

  53. Pollicino T, Squadrito G, Cerenzia G, et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 2004;126:102–110

    Article  CAS  PubMed  Google Scholar 

  54. Zeuzem S, Feinman SV, Rasenack J, et al. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 2000;343:1666–1672

    Article  CAS  PubMed  Google Scholar 

  55. Lee SD, Yu ML, Cheng PN, et al. Comparison of a 6-month course peginterferon alfa-2b plus ribavirin and interferon alfa-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan. J Viral Hepat 2005;12:283–291

    Article  PubMed  Google Scholar 

  56. Yu ML, Dai CY, Huang JF, et al. Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial. Hepatology 2008;47:1884–1893

    Article  CAS  PubMed  Google Scholar 

  57. Villa E, Grottola A, Buttafoco P, et al. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial. Am J Gastroenterol 2001;96:2973–2977

    CAS  PubMed  Google Scholar 

  58. Liu CJ, Chen PJ, Lai MY, Kao JH, Jeng YM, Chen DS. Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients. Hepatology 2003;37:568–576

    Article  CAS  PubMed  Google Scholar 

  59. Chuang WL, Dai CY, Chang WY, et al. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. Antivir Ther 2005;10:125–133

    CAS  PubMed  Google Scholar 

  60. Hung CH, Lee CM, Lu SN, et al. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection. J Gastroenterol Hepatol 2005;20:727–732

    Article  CAS  PubMed  Google Scholar 

  61. Liu CJ, Chen PJ, Chen DS. A forgotten population with chronic hepatitis C infection: subjects coinfected with hepatitis B virus. Hepatology. 2004;40:266

    Article  PubMed  Google Scholar 

  62. Asian Pacific Association for the Study of the Liver (APASL). Hepatitis C Working Party. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J Gastroenterol Hepatol 2007;22:615–633

    PubMed  Google Scholar 

  63. Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA 2007;297:724–732

    Article  CAS  PubMed  Google Scholar 

  64. Marrone A, Zampino R, D’Onofrio M, Ricciotti R, Ruggiero G, Utili R. Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection. J Hepatol 2004;41:1064–1065

    Article  CAS  PubMed  Google Scholar 

  65. Gehenot M, Marcellin P, Colin JF, Martinot M, Benhamou JP, Erlinger S. Alpha interferon therapy in HBsAg positive patients with chronic hepatitis C. Hepatology 1995;22:116A

    Google Scholar 

  66. Liaw YF, Chien RN, Lin SM, et al. Response of patients with dual hepatitis B virus and C virus infection to interferon therapy. J Interferon Cytokine Res 1997;17:449–452

    Article  CAS  PubMed  Google Scholar 

  67. Guptan RC, Thakur V, Raina V, Sarin SK. Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. J Gastroenterol Hepatol 1999;14:893–898

    Article  CAS  PubMed  Google Scholar 

  68. Utili R, Zampino R, Bellopede P, et al. Dual or single hepatitis B and C virus infections in childhood cancer survivors: long-term follow-up and effect of interferon treatment. Blood 1999;94:4046–4052

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from the National Taiwan University Hospital; the National Science Council; and Department of Health, Executive Yuan, Taiwan.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Graduate Institute of Clinical Medicine, Hepatitis Research Center, National Taiwan University College of Medicine and National Taiwan University Hospital, 1 Chang-Te Street, Taipei, 10002, Taiwan

    Chun-Jen Liu, Pei-Jer Chen & Ding-Shinn Chen

Authors
  1. Chun-Jen Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pei-Jer Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ding-Shinn Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pei-Jer Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, CJ., Chen, PJ. & Chen, DS. Dual chronic hepatitis B virus and hepatitis C virus infection. Hepatol Int 3, 517–525 (2009). https://doi.org/10.1007/s12072-009-9147-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-009-9147-9

Keywords

Search

Navigation